AKT1 and cancer: Because the expression of DNMT3B plays a key role in the epigenetic silencing of specific genes during the initial phase of carcinogenesis, and the increase in DNMT3B is mediated by the activation of the Akt pathway induced by ROS, these results reflect the influence of PM-mediated oxidative stress in cancer-driver epigenetic changes [115].